Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $68.02 Billion |
|---|---|
| Enterprise Value | $4.34 Trillion |
| Annual dividend | $1.28 |
| Dividend yield | 2.92% |
| Earnings per Share | $123.03 |
| Beta | 0.09 |
| Outstanding Shares | 1,579,922,000 |
| P/E Ratio | 28.29 |
|---|---|
| PEG | -1.63 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 0.92 |
| Enterprise Value to EBIT | 5.75 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 1.08 |
| Debt to Equity | 0.63 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the Unite...